Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST

Clinical trial NCT06735820 · RECRUITING

Trial details

NCT number: NCT06735820
Sponsor: AeRang Kim
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Peripheral Nerve Sheath Tumor (MPNST)Neurofibromatosis 1 (NF1)Atypical Neurofibroma

Start date: 2026-06-01
Primary completion: 2027-10-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.